DELESTROGEN Reviews

Average Rating: 3.6 (3 Ratings)

Filter Results

Compare DELESTROGEN with similar:
 ESTROGENS PROGESTINS

 Type: Rx Drug
  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR DELESTROGENCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 2  Surgical Menopause Headaches, extreme weight gain, hair loss, nausea, carb cravings, moodiness, depression, dizziness, fainting, water retention, acid reflux, vision changes, extreme fatigue, greatly increased sex drive, breast pain, back pain, elevated blood pressure It controls my menopause symptoms flawlessly. That said, I think the side effects may kill me. Back to the drawing board. F 32 3 months
20 MG 1X M
12/21/2011
Email
 5  Surgical Menopause Slight weight gain, cravings for carbs. Slight hair loss. This is the only HRT that has worked for me since my hysterectomy. I have no appreciable side effects, and am having no menopausal symptoms! It's been my miracle drug! F 32 2 months
20 MG 1X M
11/11/2011
Email
 4  perimenopause makes me a little spacey; some headaches at first; overall a miracle drug not only for bad perimenopause symptoms but also for mood ~ has taken away most of my depression. ladies, try this in combo w/ an ssri, or try this first. it may be your hormones that are out of whack, not your brain chemistry. F 43 6 months
5/31/2009
  

DELESTROGEN  (ESTRADIOL VALERATE):  This medication is a female hormone (estrogen). It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure) and by men to treat prostate cancer.   (Sources: U.S. Centers for Medicare Services, FDA)

BACK TO TOP